Help collect valuable data from psoriasis patients in a clinical setting.
The National Psoriasis Foundation and CorEvitas, LLC launched a national psoriasis patient registry in 2015. The registry collects and analyzes data from psoriasis patients in a clinical setting.
The primary objective is to use these data to study the safety of FDA-approved systemic therapies. The secondary objective is to study comparative effectiveness, including patient-reported outcomes.
The registry is seeking patients who are:
Diagnosis
Diagnosed with psoriasis
Age
18 or older
Treatment
Recently started a biologic within the past 12 months (combination therapy – for example, a biologic with a topical steroid – will not disqualify someone)
Patients complete questionnaires during routine appointments with their dermatologist. Their dermatologist follows up approximately every six months. The questionnaires take about 10 to 15 minutes.
How to Contribute to the Registry:
Patients
Ask your dermatologist if he or she is currently participating in the CorEvitas Registry.
Dermatologists
The registry is still accepting a limited number of sites for dermatologists that treat patients with moderate to severe psoriasis with systemic treatments. Please contact CorEvitas if you are interested or have questions.
Questions or concerns?
Please reach out to us with any questions or if you are interested in participating in this program.
We use cookies to offer you a better experience and analyze our site traffic. By continuing to use this website, you consent to the use of cookies in accordance with our Privacy Policy.